PHI-501, a novel pan-RAF/DDRs dual kinase inhibitor, overcomes BRAF or MEK inhibitor resistance in melanoma

被引：0
|
作者：
Kim, Sue Min
Park, Jung Hee
Nam, Ky-Youb
Han, June H-J
Kim, Kyu-Tae
Yoon, Jeong Hyeok
Sengupta, Sandip
Sim, Taebo
Shin, Sang Joon
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-411
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
411
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHI-501 is a novel potent next-generation pan-RAF/DDRs inhibitor, and overcomes resistance to RAF or MEK inhibitor in melanoma via dual inhibition of RAF and DDR1/2 signaling
    Kim, Sue Min
    Cho, Sungmin
    Sung, Gi-Jun
    Nam, Ky-Youb
    Han, June
    Shin, Sang Joon
    CANCER RESEARCH, 2024, 84 (06)
  • [2] PHI-501, a novel and potent pan-RAF inhibitor in metastatic melanoma
    Kim, Namkyeong
    Park, Jung Hee
    Nam, Ky-Youb
    Han, June H-J
    Kim, Kyu-Tae
    Sengupta, Sandip
    Yoon, Jeong Hyeok
    Sim, Taebo
    CANCER RESEARCH, 2023, 83 (07)
  • [3] A highly selective dual Haspin-kinase and PIM-inhibitor overcomes RAF/MEK-inhibitor resistance in melanoma
    Melms, Johannes C.
    Vallabhaneni, Sreeram
    Mills, Caitlin E.
    Sorger, Peter K.
    Wucherpfennig, Kai
    Izar, Benjamin
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Antitumor Activity of the Selective Pan-RAF Inhibitor TAK-632 in BRAF Inhibitor-Resistant Melanoma
    Nakamura, Akito
    Arita, Takeo
    Tsuchiya, Shuntarou
    Donelan, Jill
    Chouitar, Jouhara
    Carideo, Elizabeth
    Galvin, Katherine
    Okaniwa, Masanori
    Ishikawa, Tomoyasu
    Yoshida, Sei
    CANCER RESEARCH, 2013, 73 (23) : 7043 - 7055
  • [5] Combined Pan-RAF and MEK Inhibition Overcomes Multiple Resistance Mechanisms to Selective RAF Inhibitors
    Whittaker, Steven R.
    Cowley, Glenn S.
    Wagner, Steve
    Luo, Flora
    Root, David E.
    Garraway, Levi A.
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (12) : 2700 - 2711
  • [6] Characterization of the selective pan-RAF inhibitor TAK-632 with antitumor activity in BRAF inhibitor-resistant melanoma
    Nakamura, Akito
    Arita, Takeo
    Tsuchiya, Shuntarou
    Donelan, Jill
    Chouitar, Jouhara
    Carideo, Elizabeth
    Galvin, Katherine
    Okaniwa, Masanori
    Ishikawa, Tomoyasu
    Yoshida, Sei
    CANCER RESEARCH, 2014, 74 (19)
  • [7] BIIB024, a potent pan-Raf kinase inhibitor for melanoma and solid tumors
    Elenbaas, B.
    Singh, L.
    Boccia, A.
    Cullen, P.
    Peng, H.
    Rohde, E.
    Raimundo, B.
    Kumaravel, G.
    Joseph, I.
    EJC SUPPLEMENTS, 2010, 8 (07): : 40 - 41
  • [8] Preclinical characterization of QLH11906, a novel pan-RAF inhibitor
    Cheng, Zhe
    Chen, Fei
    Liu, Xile
    Gao, Cong
    Jia, Linchao
    Lao, Yuanzhi
    CANCER RESEARCH, 2022, 82 (12)
  • [9] PHI-501, a potent and novel inhibitor of NRAS mutated acute myeloid leukemia.
    Nam, Ky-Youb
    Park, Jung Hee
    Kim, Kyung Ah
    Shin, Inje
    Han, June H-J
    Kim, Kyu-Tae
    Yoon, Jeong Hyeok
    Cho, Hanna
    Choi, Seung-Hye
    Sengupta, Sandip
    Sim, Taebo
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Dual inhibitor of immunokinase and pan-RAF for the treatment of KRAS-mutated cancers
    Hong, Sungpyo
    Ahn, Soon Kil
    Kwon, Ho-Seok
    Park, Yongbin
    Ki, Min-Hyo
    Shin, Hee Jong
    CANCER RESEARCH, 2018, 78 (13)
12345